Explore Effect of Jieyu Qutan Huazhuo Prescription on Gut-liver Axis of Rats with High-fat Diet Based on 16S rDNA Sequencing
10.13422/j.cnki.syfjx.20210327
- VernacularTitle:基于16S rDNA测序的肠道菌群探讨解郁祛痰化浊方对高脂饮食大鼠肠-肝轴的影响
- Author:
Na LI
1
;
Yang-yang WU
2
;
Jin-long DUAN
1
;
Xu-tong ZHENG
1
;
Kui-wu YAO
1
Author Information
1. Guang'anmen Hospital，China Academy of Chinese Medical Sciences，Beijing 100053，China
2. Luoyang Hospital of Traditional Chinese Medicine，Luoyang 471000，China
- Publication Type:Research Article
- Keywords:
Jieyu Qutan Huazhuo prescription;
gut microbiota;
hyperlipidemia;
gut-liver axis;
16S rDNA sequencing
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2021;27(9):77-85
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the effect of Jieyu Qutan Huazhuo prescription（JQHP） on the gut microbiota of rats with high-fat diet，and to explore the effect of Chinese medicine on the regulation of gut microflora and the restoration of gut-liver axis balance. Method:Seventy male SPF Wistar rats were randomly divided into a normal group of 10 and a model group of 60. Mice in the normal group were fed with normal diet and mice in the model group were fed high-fat diet. After 12 weeks，the model group was randomly divided into 6 groups with 10 animals in each group，namely the model group，Xuezhikang group，Liputuo group，and low，medium and high-dose groups of JQHP. The JQHP low-dose，medium-dose and high-dose rats were intragastrically daministered with 0.4，0.8，1.6 g·kg-1，respectively， rats in Liputuo group with Liputuo 2 mg·kg-1，rats in Xuezhikang group with Xuezhikang 0.1 g·kg-1. The rats in the normal group and the model group were intragastrically administered with the same amount of distilled water. Stool were collected after continuous gavaging for 8 weeks，16S rRNA gene sequencing was performed，blood was collected from the abdominal aorta to detect blood lipids，and the liver tissue and ileum tissue were collected for hematoxylin and eosin （HE） staining for pathomorphological observation. Result:Compared with the normal group，the total cholesterol （TC），triglyceride （TG），and low-density lipoprotein （LDL-C） in the model group were significantly increased，while the high-density lipoprotein （HDL-C） was decreased （P<0.01）. Compared with the model group，TC and TG values were decreased significantly in Xuezhikang group （P<0.01），HDL-C value was increased （P<0.05），and in the Liputuo group TC and TG were decreased significantly （P<0.01）. Compared with the model group，the middle-dose group of JQHP had a certain alleviating effect on liver steatosis and could reduce the infiltration of inflammatory cells. The JQHP could improve the proliferation of lymphoid tissues in the ileal structure，and the middle-dose group has the most significant effect. The results of Shannon curve showed that compared with the normal group，the middle-dose group of JQHP increased significantly （P<0.01）. Compared with the model group，the middle and high-dose group of JQHP increased （P<0.05，P<0.01）. Compared with the middle-dose group of JQHP，the other drug group decreased （P<0.05，P<0.01）. Principal component diversity analysis（PCA） showed that the diversity and abundance in the middle-dose JQHP group were higher than those in other drug groups. In linear discriminant analysis（LDA），compared with the normal group，Bacteroidia，Ruminococcaceae，Bacteroides S24-7，and Rumenococcus UCG-005 were down-regulated in the model group（P<0.01），while the orders of Desulfovibrionales，Erysipelotrichales and Lachnospiraceae were up-regulated in the model group （P<0.05，P<0.01）. Compared with the model group，the Bacteroidia，Ruminococcaceae，Bacteroides S24-7，and Rumencoccus UCG-005 in the middle-dose JQHP group were increased （P<0.05，P<0.01），and the orders of Erysipelotrichales were decreased （P<0.01）. Compared with the middle-dose JQHP group，Bacteroidia，Ruminococcaceae，Bacteroides S24-7，and Rumencoccus UCG-005 in other drug groups were reduced（P<0.05，P<0.01），and the order of Erysipelotrichales and Lachnospiraceae were increased （P<0.05，P<0.01）. Conclusion:JQHP can regulate the abundance and diversity of the gut microbiota，improve the state of liver tissue and ileum mucosa，regulate blood lipid levels，and restore the normal intestinal ecological environment. It may be related to the regulation of inflammation-related gut microbiota in order to restore the balance of the gut-liver axis，and the middle-dose JQHP group has the best effect.
